Particles coated with zwitterionic polymers comprising sulfobetaine or carboxybetaine

US9598544B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9598544-B2
Application numberUS-201414184540-A
CountryUS
Kind codeB2
Filing dateFeb 19, 2014
Priority dateAug 25, 2005
Publication dateMar 21, 2017
Grant dateMar 21, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Nanoparticles zwitterionic polymers grafted thereto or grafted therefrom, and methods for making and using the nanoparticles. Zwitterionic nanogels, and methods for making and using the nanogels.

First claim

Opening claim text (preview).

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1. A surface having a layer of sulfobetaine polymers coupled thereto, wherein the density of the sulfobetaine polymers in the layer provides a surface having a fibrinogen adsorption of less than about 30 ng/cm 2 in a fibrinogen binding assay when the surface is incubated at 37° C. for 90 minutes with a 1.0 mg/mL fibrinogen solution (0.15 M phosphate buffered saline at pH 7.4). 2. The surface of claim 1 , wherein the sulfobetaine polymers are prepared from one or more monomers selected from the group consisting of a sulfobetaine acrylate, a sulfobetaine acrylamide, a sulfobetaine methacrylate, and mixtures thereof. 3. The surface of claim 1 , wherein the layer of sulfobetaine polymers comprises an interpenetrating sulfobetaine polymer network. 4. The surface of claim 3 , wherein the interpenetrating sulfobetaine polymer network further comprises one or more polymers selected from the group consisting of a polyurethane, a silicone, a polyester, a polyethylene, and a polyamide. 5. The surface of claim 1 , wherein the layer of sulfobetaine polymers comprises a sulfobetaine copolymer. 6. The surface of claim 1 , wherein the layer comprises sulfobetaine polymers covalently attached to a substrate surface. 7. The surface of claim 1 on all or part of a particle. 8. The surface of claim 1 , wherein the fibrinogen adsorption is less than 10 ng/cm 2 . 9. The surface of claim 1 , wherein the fibrinogen adsorption is less than 5 ng/cm 2 . 10. The surface of claim 1 , wherein the fibrinogen adsorption is less than 0.3 ng/cm 2 . 11. The surface of claim 1 , wherein the sulfobetaine polymers are prepared from one or more monomers selected from the group consisting of a sulfobetaine vinyl compound, a sulfobetaine epoxide, and mixtures thereof. 12. A substrate comprising a surface having a layer of sulfobetaine polymers grafted from the surface, wherein the density of the sulfobetaine polymers in the layer provides a surface having a fibrinogen adsorption of less than about 30 ng/cm 2 in a fibrinogen binding assay when the surface is incubated at 37° C. for 90 minutes with a 1.0 mg/mL fibrinogen solution (0.15 M phosphate buffered saline at pH 7.4). 13. The substrate of claim 12 , wherein the sulfobetaine polymers are prepared from one or more monomers selected from the group consisting of a sulfobetaine acrylate, a sulfobetaine acrylamide, a sulfobetaine methacrylate, and mixtures thereof. 14. The substrate of claim 12 , wherein the layer of sulfobetaine polymers comprises a sulfobetaine copolymer. 15. The substrate of claim 12 , wherein the fibrinogen adsorption is less than 10 ng/cm 2 . 16. The substrate of claim 12 , wherein the fibrinogen adsorption is less than 5 ng/cm 2 . 17. The substrate of claim 12 , wherein the fibrinogen adsorption is less than 0.3 ng/cm 2 . 18. The substrate of claim 12 on or forming all or part of a particle. 19. The substrate of claim 12 , wherein the sulfobetaine polymers are prepared from one or more monomers selected from the group consisting of a sulfobetaine vinyl compound, a sulfobetaine epoxide, and mixtures thereof.

Assignees

Inventors

Classifications

  • C08J3/075Primary

    Macromolecular gels · CPC title

  • with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton · CPC title

  • Ingredients agglomerated by treatment with a binding agent · CPC title

  • Atom Transfer Radical Polymerization [ATRP] or reverse ATRP · CPC title

  • at least one of the nitrogen atoms being part of any of the groups [IMAGE cpc-sch-C07C-0976.gif], X being a hetero atom, Y being any atom · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9598544B2 cover?
Nanoparticles zwitterionic polymers grafted thereto or grafted therefrom, and methods for making and using the nanoparticles. Zwitterionic nanogels, and methods for making and using the nanogels.
Who is the assignee on this patent?
Univ Washington, Univ Washington Through Its Center For Commercialization
What technology area does this patent fall under?
Primary CPC classification C08J3/075. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).